🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsClinical Trials & ResearchCan we talk about how SLOW the FDA is Page 7

Can we talk about how SLOW the FDA is

KarenAZ_mom Mon, Apr 20, 2026 at 10:27 AM 38 replies 1,036 viewsPage 7 of 8
wanda_boise
Member
412
1,890
Aug 2024
Boise, ID
May 17, 2026 at 10:17 AM#31
dan_philly said:
If you are going to change something, change one thing and give it long enough to express itself.

This is exactly what I could not find anywhere else.

24 24DanielChem_CHI, marco_milano, pam_columbus and 21 others
Reply Quote Save Share Report
Dr.BariatricHTX
Senior Member
1,456
7,234
Feb 2024
Houston, TX
May 19, 2026 at 11:59 AM#32

Clinical perspective, offered as context rather than as advice. Worth answering the question that was asked rather than the one behind it. The narrow version usually has an answer; the broad version usually does not, and answering the broad one is how a thread stops being useful.

If somebody has the primary source to hand I would rather cite it than paraphrase it.

23 23pete_RVA, CarlaRPh_TPA, steph_laguna and 20 others
Reply Quote Save Share Report
JennaRN
Senior Member
1,987
8,923
Mar 2024
Colorado
Online
May 21, 2026 at 1:39 PM#33
Dr.BariatricHTX said:
Worth answering the question that was asked rather than the one behind it.

Same experience, arrived at from the opposite direction. I had assumed I was the exception until I read this.

22 22BiostatsBrad, PeptideSynthNJ, Dr.KarenChen and 19 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
JakeSmashed95
Member
412
1,890
Aug 2024
Arkansas
Online
May 23, 2026 at 3:18 PM#34
Dr.BariatricHTX said:
Worth answering the question that was asked rather than the one behind it.

Adding the part of the answer the thread has not reached. Take it one variable at a time. Almost every unanswerable question in these threads is unanswerable because three things changed in the same fortnight, and no amount of subsequent argument can untangle them after the fact.

Last edited: May 23, 2026 at 8:18 PM
21 21Dr.LipidDallas, alex_tucson, kevin_tulsa and 18 others
Reply Quote Save Share Report
Dr.RaviCardio
VIP Member
2,890
15,678
Jan 2024
New York, NY
May 25, 2026 at 4:57 PM#35

One concrete data point for the thread. Worth stating the units and the reference range whenever you post a number here. A large fraction of the apparent disagreement in these threads is two people using different units and both being right.

20 20jason_sac26, chris_chi24, tampaLisa73 and 17 others
Reply Quote Save Share Report

Similar Threads

FLOW trial: semaglutide renal outcomes — NEJM publication review14 replies
SELECT trial: semaglutide 2.4mg cardiovascular outcomes — 4yr data9 replies
TRIUMPH program (retatrutide) — Phase 3 trial design and endpoints13 replies
Orforglipron ATTAIN trials — oral non-peptide GLP-1 agonist8 replies
CagriSema (amylin + semaglutide) — REDEFINE Phase 3 results20 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register